C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom

Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
08/2011
08/31/2011	CN102171204A 8-substituted isoquinoline derivative and use thereof
08/31/2011	CN102171203A Piperazine compounds with herbicidal effect
08/31/2011	CN102171202A Pyridine and pyrimidine based compounds as WNT signaling pathway inhibitors for the treatment of cancer
08/31/2011	CN102171190A Insecticidal benzenedicarboxamide derivative
08/31/2011	CN102167695A Benzimidazole-carbonyl-pyridine-amino-ehtyl-propionate hemihyrate and its use
08/31/2011	CN102166211A Use of derivatives of 1-deoxynojiri mycin containing 1,2,3-triazoles as alpha-glucosidase inhibitors
08/31/2011	CN101395134B 17 beta hsd type 5 inhibitor
08/31/2011	CN101384550B Amide derivative or salt thereof
08/31/2011	CN101316818B 3-amino-1-arylpropyl indoles and aza-substituted indoles
08/31/2011	CN101268051B Isotopically substituted proton pump inhibitors
08/31/2011	CN101203489B Oxindole derivatives
08/31/2011	CN101119968B Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1
08/30/2011	US8008505 Indazole or 4,5,6,7-tetrahydro-indazole derivatives
08/30/2011	US8008494 2-(4-{4-[N'-(3,5-diamino-6-chloropyrazine-2-carbonyl)guanidino]-butyl}phenoxy)-N-(3-dimethylaminopropyl)acetamide dimethanesulfonate; promoting hydration of mucosal surfaces; Sjogren's disease, esophagitis, pneumonia, asthma, otitis, constipation, chronic diverticulitis, rhinosinusitis
08/30/2011	US8008491 poly(adenosine 5'-diphosphate ribose) polymerase inhibitors such as 1-phenyl-2-(piperazin-1-yl)-1,3-dihydropyrrolo[2,3-b]pyridine-3-carboxaldehyde, used in the treatment and/or prevention central nervous system and cardiovascular disorders
08/30/2011	US8008490 Polymorphic forms of aripiprazole and method
08/30/2011	US8008488 Pyrimidin-2-one compounds and their use as dopamine D3 receptor ligands
08/30/2011	US8008483 sEH inhibitors and their use
08/30/2011	US8008327 Indazole compounds as CCR1 receptor antagonists
08/30/2011	US8008326 4-benzyledene-piperidin derivatives
08/30/2011	US8008324 Antitumor agents; N-propargyl-N-(2-methyl-6-quinolyl)-[1-(4-chlorobenzyl)indol-3-yl]glyoxylamide
08/30/2011	US8008312 CXCR4 antagonists for the treatment of HIV infection
08/30/2011	US8008305 TAAR1 ligands
08/30/2011	US8008302 ((2S,3S) N,2-dihydroxy-5-methyl-3-{[4-(2-pyridinyl)-1-piperazinyl]carbonyl}hexanamide; for treatment and/or prevention of disorders related to autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, stroke, cancer, pre-term labor, endometriosis
08/30/2011	US8008301 Histamine H3 receptor agents, preparation and therapeutic uses
08/30/2011	US8008300 Therapeutic agents useful for treating pain
08/30/2011	US8008299 Urotensin II receptor antagonists
08/30/2011	US8008295 Tyrosine kinase inhibitors
08/30/2011	US8008291 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5 receptor antagonists
08/30/2011	US8008287 Use treating HIV and AIDS; tricyclic compounds such as those based on 5-sulfonamido-9-hydroxy-6,8-dihydrdo-7H-pyrrolo[3,4-g]quinoline-8-one
08/30/2011	US8008279 Compound—827
08/30/2011	US8008278 Diarylmethyl and related compounds
08/30/2011	US8007767 Amino methyl imidazoles and related compounds as C5a receptor modulators
08/30/2011	CA2672373C Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
08/30/2011	CA2645294C Dibenzyl amine compounds and derivatives
08/30/2011	CA2531165C A method for the preparation of enantiomerically pure mirtazapine
08/30/2011	CA2440473C Metalloproteinase inhibitors
08/30/2011	CA2406392C Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
08/30/2011	CA2372150C Therapeutic applications of pro-apoptotic benzodiazepines
08/25/2011	WO2011103289A2 Imidazole-2, 4-dione inhibitors of casein kinase 1
08/25/2011	WO2011103202A2 Androgen receptor modulators and uses thereof
08/25/2011	WO2011103196A1 Aryl carboxamide derivatives as sodium channel inhibitors for treatment of pain
08/25/2011	WO2011102514A1 Aromatic ring compound
08/25/2011	WO2011102348A1 Hydrazide chelate complex compound and optical recording medium using same
08/25/2011	WO2011101304A2 Piperidine derivatives
08/25/2011	WO2011100840A1 Substituted 2-imidazolidones and analogs
08/25/2011	WO2011100838A1 Derivatives of 1-phenyl-1,5-dihydro-benzo[b] [1.4]diazepine-2.4-dione as inhibitors of hiv replication
08/25/2011	WO2011046964A3 Inhibitors of bruton's tyrosine kinase
08/25/2011	WO2011011522A3 Potent small molecule inhibitors of autophagy, and methods of use thereof
08/25/2011	US20110208064 Curcumin Derivatives for Amyloid-Beta Plaque Imaging
08/25/2011	US20110207929 Process for preparing aminocrotonylamino-substituted quinazoline derivatives
08/25/2011	US20110207782 Nicotine-containing product
08/25/2011	US20110207781 Novel microbiocides
08/25/2011	US20110207780 Therapeutic Salt Compositions and Methods
08/25/2011	US20110207779 Process for the preparation of esomeprazole magnesium
08/25/2011	US20110207777 Benzimidazoles which have activity at m1 receptor and their uses in medicine
08/25/2011	US20110207773 Novel phenyl-quinoline-carboxylic acid pyridine derivatives useful as modulators of nicotinic acetylcholine receptors
08/25/2011	US20110207772 Glycine Chroman-6-Sulfonamides for Use as Inhibitors of Diacylglycerol Lipase
08/25/2011	US20110207771 N-(l-alkyl-2-phenylethyl)-carboxamide derivatives and use thereof as fungicides
08/25/2011	US20110207763 8-carboxamido-2,6-methano-3-benzazocines
08/25/2011	US20110207750 Benzimidazole and aza-benzimidazole carboxamides
08/25/2011	US20110207747 2,5-Disubstituted Phenyl Carboxamide Orexin Receptor Antagonists
08/25/2011	US20110207743 Pyrazolylaminopyridines as inhibitors of fak
08/25/2011	US20110207739 Novel 1, 2-Disubstituted Amido-anthraquinone Derivatives, Preparation Method and application thereof
08/25/2011	US20110207737 Substituted bicyclic amines for the treatment of diabetes
08/25/2011	US20110207735 Cyanopyrimidinones
08/25/2011	US20110207734 Azine Derivatives and Methods of Use Thereof
08/25/2011	US20110207733 Pyrimidine derivatives for treatment of alzheimer's disease
08/25/2011	US20110207731 Substituted 4-(indazolyl)-1,4-dihydropyridines and methods of use thereof
08/25/2011	US20110207727 Thio-subsituted Anthra [1, 2-d] imidazole- 6, 11-dione Dervatives, Preparation Method and application thereof
08/25/2011	US20110207726 Inhibitors of Human Cathepsin L, Cathepsin B, and Cathepsin S
08/25/2011	US20110207720 Quinolin-4-one and 4-oxodihyrdocinnoline derivatives as inhibitors of poly(adp-ribose) polymerase (parp)
08/25/2011	US20110207719 Novel Anthra [1, 2-d]imidazole-6,11-dione Derivatives, Preparation Method and application thereof
08/25/2011	US20110207714 Serotonin receptor modulators
08/25/2011	US20110207712 Phosphatidylinositol 3-Kinase Inhibitors And Methods Of Their Use
08/25/2011	US20110207711 Therapeutic Compounds
08/25/2011	US20110207704 Novel Oxadiazole Compounds
08/25/2011	US20110207699 Anti-Viral Compounds
08/25/2011	US20110207698 Heteroaryl-substituted dicyanopyridines and their use
08/25/2011	US20110206783 P2x3, receptor antagonists for treatment of pain
08/25/2011	US20110206690 Dimeric iap inhibitors
08/25/2011	US20110204354 Indenopyrene compound and organic light-emitting device using the compound
08/25/2011	CA2790692A1 Triazolones as fatty acid synthase inhibitors
08/25/2011	CA2789711A1 Aryl carboxamide derivatives as sodium channel inhibitors for treatment of pain
08/25/2011	CA2789058A1 Piperidine derivatives
08/25/2011	CA2787860A1 Substituted 2-imidazolidones and analogs
08/25/2011	CA2787083A1 Androgen receptor modulators and uses thereof
08/24/2011	EP2360155A1 2-aminopyridin-4-one and 2-aminopyridine derivative both having bace1-inhibiting activity
08/24/2011	EP2360154A1 Deuterated vitamin d compounds
08/24/2011	EP2359831A2 Therapeutic applications of pro-apoptotic benzodiazepines
08/24/2011	EP2358702A2 Piperidine compounds, pharmaceutical composition comprising the same and its use
08/24/2011	EP2358701A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
08/24/2011	EP2358700A1 Pyrrole derivatives for use as plant growth regulators
08/24/2011	EP2358699A1 Isothiazole and pyrazole derivatives for use as plant growth regulators
08/24/2011	EP2358698A1 Tetrasubstituted pyridazine hedgehog pathway antagonists
08/24/2011	EP2358697A1 Isoindoline compounds for use in the treatment of cancer
08/24/2011	EP2358686A1 Aryl methyl benzoquinazolinone m1 receptor positive allosteric modulators
08/24/2011	EP2358684A1 Low molecular weight thyroid stimulating hormone receptor (tshr) agonists
08/24/2011	EP2358682A2 Isoquinolone derivatives as inhibitors of plavivirus replication
08/24/2011	EP2358681A1 Substituted 4-(1,2,3,4-tetrahydroisochinolin-2-yl)-4-oxo-butyric acid amide as kcnq2/2 modulators

1 ... 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 ... 1080